Up-regulation of interleukin-6 and vascular endothelial growth factor-A in the synovial fluid of temporomandibular joints affected by synovial chondromatosis

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 2, 2013, Pages 164-169

  Wake, Masahiro ^a,b   Hamada, Yoshiki ^a   Kumagai, Kenichi ^a,b   Tanaka, Nobuho ^b   Ikeda, Yasuko ^b   Nakatani, Yasunori ^c   Suzuki, Ryuji ^b   Fukui, Naoshi ^d  

^a TSURUMI UNIVERSITY   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^c Toshiba Rinkan Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Interleukin 6 (IL 6); Synovial chondromatosis; Synovitis; Temporomandibular joint; Vascular endothelial growth factor A (VEGF A)

Indexed keywords

AGGRECAN; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; ACAN PROTEIN, HUMAN; AUTACOID; IL10 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; PROTEIN; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHONDROMATOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; SYNOVIAL FLUID; SYNOVIOCYTE; TEMPOROMANDIBULAR JOINT; UPREGULATION; VERY ELDERLY; ARTHROSCOPY; CHEMISTRY; COMPARATIVE STUDY; JOINT DESTRUCTION; LAVAGE; METHODOLOGY; PATHOLOGY; SYNOVIUM; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; ARTHROSCOPY; CHONDROMATOSIS, SYNOVIAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; JOINT LOOSE BODIES; MALE; MIDDLE AGED; PROTEINS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS; THERAPEUTIC IRRIGATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883028048     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2012.03.004     Document Type: Article

References (25)

1. Holmlund AB, Eriksson L, Reinholt FP Synovial chondromatosis of the temporomandibular joint: clinical, surgical and histological aspects. Int J Oral Maxillofac Surg 2003;32:143-7.
2. Cascone P, De Biase A, De Ponte F, Saltarel A. Therapeutic planning in synovial chondromatosis of the temporomandibular joint. J Craniofac Surg 1996;7:352-7.
3. Miyamoto H, Sakashita H, Wilson D.F., Goss AN Synovial chondromatosis of the temporomandibular joint. Br J Oral Maxillofac Surg 2000;38:205-8.
4. Kenan S, Abdelwahab IF, Klein M.J., Lewis MM Case report 817: Synovial chondrosarcoma secondary to synovial chondromatosis. Skeletal Radiol 1993;22:623-6.
5. Shah SB, Ramanojam S, Gadre P.K., Gadre KS Synovial chondromatosis of temporomandibular joint: journey through 25 decades and a case report. J Oral Maxillofac Surg 2011;69:2795-814.
6. Cai XY, Yang C, Chen MJB, Zhou Q, Jin JM Arthroscopic management for synovial chondromatosis of the temporomandibular joint: a retrospective review of 33 cases. J Oral Maxillofac Surg 2012 [Epub 16 December 2011].
7. Tojyo I, Yamaguti A, Ozaki H., Yoshida H, Fujita S. The expression of fibroblast growth factor receptor-3 in synovial osteochondromatosis of the temporomandibular joint. Arch Oral Biol 2004;49:591-4.
8. Sato J, Segami N, Suzuki T., Yoshitake Y, Nishikawa K. The expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in chondrocytes in synovial chondromatosis of the temporomandibular joint. Report of two cases. Int J Oral Maxillofac Surg 2002;31:532-6.
9. Robinson D, Hasharoni A, Evron Z., Segal M, Nevo Z. Synovial chondromatosis: the possible role of FGF 9 and FGF receptor 3 in its pathology. Int J Exp Pathol 2000;81:183-9.
10. Fujita S, Iizuka T, Yoshida H., Segami N. Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint. Report of a case. Int J Oral Maxillofac Surg 1997;26:258-9.
11. Nakanishi S, Sakamoto K, Yoshitake H., Kino K, Amagasa T, Yamaguchi A. Bone morphogenetic proteins are involved in the pathobiology of synovial chondromatosis. Biochem Biophys Res Commun 2009;379:914-9.
12. Hamada Y, Kondoh T, Holmlund A.B., Sakota K., Nomura Y, Seto K. Cytokine and clinical predictors for treatment outcome of visually guided temporomandibular joint irrigation in patients with chronic closed lock. J Oral Maxillofac Surg 2008;66:29-34.
13. Kumagai K, Hamada Y, Holmlund A.B., Gotoh A., Nakaoka K, Arai G, et al The levels of vascular endothelial growth factor in the synovial fluid correlated with the severity of arthroscopically observed synovitis and clinical outcome after temporomandibular joint irrigation in patients with chronic closed lock. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:185-90.
14. von Lindern J.J., Theuerkauf I, Niederhagen B., Bergé S, Appel T, Reich RH. Synovial chondromatosis of the temporomandibular joint: clinical, diagnostic, and histomorphologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:31-8.
15. Nakaoka K, Hamada Y, Holmlund A.B., Saito T., Arai G, Horiuchi T, et al The changes of joint effusion on MRI and arthroscopic findings after visually guided TMJ irrigation correlated to the clinical outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:99-104.
16. Larheim TA, Katzberg RW, Westesson P.L., Tallents RH, Moss ME MR evidence of temporomandibular joint fluid and condyle marrow alterations: occurrence in asymptomatic volunteers and symptomatic patients. Int J Oral Maxillofac Surg 2001;30:113-7.
17. Kobayashi T, Fujikawa K, Sasazaki Y., Aoki Y Osteochondromatosis with high concentration of procollagen II C peptide in joint fluid. Knee 2002;9:165-7.
18. Palmer CD, Mutch BE, Page T.H., Horwood NJ, Foxwell BM Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2008;370:599-602.
19. Gentiletti J, Fava RA Does vascular endothelial growth factor play a role in interleukin-6 receptor antagonist therapy for rheumatoid arthritis? Arthritis Rheum 2003;48:1471-4.
20. Brenchley PE. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin Exp Immunol 2000; 121: 426-9.
21. Koch AE, Harlow LA, Haines G.K., Amento EP, Unemori EN, Wong WL, et al Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
22. Segami N, Nishimura M, Kaneyama K., Miyamaru M, Sato J, Murakami KI Does joint effusion on T2 magnetic resonance images reflect synovitis? Comparison of arthroscopic findings in internal derangements of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:341-5.
23. Westesson PL, Brooks SL Temporomandibular joint: relationship between MR evidence of effusion and the presence of pain and disk displacement. AJR 1992;159:559-63.
24. Honda K, Hamada Y, Ejima K., Tsukimura N, Kino K. Interventional radiology of synovial chondromatosis in the temporomandibular joint using a thin arthroscope. Dentomaxillofac Radiol 2008;37: 232-5.
25. Mori Y, Kakudo K, Gotoh M., Kubo H, Akiyama H, Yotsui Y., et al. A case of synovial chondromatosis of the temporomandibular joint followed for 17 years. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:e35-9.